• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管重构是肝肿瘤发生的啮齿动物模型肝癌发生早期的关键事件。

Vascular Remodeling Is a Crucial Event in the Early Phase of Hepatocarcinogenesis in Rodent Models for Liver Tumorigenesis.

机构信息

Institute of Pathology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.

Comparative Experimental Pathology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.

出版信息

Cells. 2022 Jul 6;11(14):2129. doi: 10.3390/cells11142129.

DOI:10.3390/cells11142129
PMID:35883572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9320355/
Abstract

The investigation of hepatocarcinogenesis is a major field of interest in oncology research and rodent models are commonly used to unravel the pathophysiology of onset and progression of hepatocellular carcinoma. HCC is a highly vascularized tumor and vascular remodeling is one of the hallmarks of tumor progression. To date, only a few detailed data exist about the vasculature and vascular remodeling in rodent models used for hepatocarcinogenesis. In this study, the vasculature of HCC and the preneoplastic foci of alteration (FCA) of different mouse models with varying genetic backgrounds were comprehensively characterized by using immunohistochemistry (CD31, Collagen IV, αSMA, Desmin and LYVE1) and RNA in situ hybridization (VEGF-A). Computational image analysis was performed to evaluate selected parameters including microvessel density, pericyte coverage, vessel size, intratumoral vessel distribution and architecture using the Aperio ImageScope and Definiens software programs. HCC presented with a significantly lower number of vessels, but larger vessel size and increased coverage, leading to a higher degree of maturation, whereas FCA lesions presented with a higher microvessel density and a higher amount of smaller but more immature vessels. Our results clearly demonstrate that vascular remodeling is present and crucial in early stages of experimental hepatocarcinogenesis. In addition, our detailed characterization provides a strong basis for further angiogenesis studies in these experimental models.

摘要

肝癌发生的研究是肿瘤学研究的一个主要领域,啮齿动物模型通常用于揭示肝细胞癌发病和进展的病理生理学。HCC 是一种高度血管化的肿瘤,血管重塑是肿瘤进展的标志之一。迄今为止,关于用于肝癌发生的啮齿动物模型中的血管和血管重塑,仅有少数详细数据存在。在这项研究中,使用免疫组织化学(CD31、Collagen IV、αSMA、Desmin 和 LYVE1)和 RNA 原位杂交(VEGF-A),全面描述了具有不同遗传背景的不同小鼠模型中的 HCC 和癌前病变(FCA)的血管。使用 Aperio ImageScope 和 Definiens 软件程序进行计算图像分析,以评估包括微血管密度、周细胞覆盖率、血管大小、肿瘤内血管分布和结构在内的选定参数。HCC 表现出明显较少的血管,但较大的血管大小和增加的覆盖率,导致更高程度的成熟,而 FCA 病变则表现出更高的微血管密度和更多较小但更不成熟的血管。我们的研究结果清楚地表明,血管重塑在实验性肝癌发生的早期阶段存在且至关重要。此外,我们的详细特征为这些实验模型中的进一步血管生成研究提供了坚实的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9e/9320355/ff5696700dfd/cells-11-02129-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9e/9320355/8ec993ec6700/cells-11-02129-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9e/9320355/1312ff040e7f/cells-11-02129-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9e/9320355/defa982454b8/cells-11-02129-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9e/9320355/829524375cde/cells-11-02129-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9e/9320355/da3f0c73b632/cells-11-02129-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9e/9320355/17b08f10f9bf/cells-11-02129-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9e/9320355/ff5696700dfd/cells-11-02129-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9e/9320355/8ec993ec6700/cells-11-02129-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9e/9320355/1312ff040e7f/cells-11-02129-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9e/9320355/defa982454b8/cells-11-02129-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9e/9320355/829524375cde/cells-11-02129-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9e/9320355/da3f0c73b632/cells-11-02129-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9e/9320355/17b08f10f9bf/cells-11-02129-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9e/9320355/ff5696700dfd/cells-11-02129-g007.jpg

相似文献

1
Vascular Remodeling Is a Crucial Event in the Early Phase of Hepatocarcinogenesis in Rodent Models for Liver Tumorigenesis.血管重构是肝肿瘤发生的啮齿动物模型肝癌发生早期的关键事件。
Cells. 2022 Jul 6;11(14):2129. doi: 10.3390/cells11142129.
2
Endothelial cells do not arise from tumor-initiating cells in human hepatocellular carcinoma.内皮细胞并非源自人类肝细胞癌中的肿瘤起始细胞。
BMC Cancer. 2013 Oct 20;13:485. doi: 10.1186/1471-2407-13-485.
3
Microvessel density and angiogenesis in primary hepatic malignancies: Differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.原发性肝脏恶性肿瘤中的微血管密度与血管生成:CD31和VEGFR-2在肝细胞癌和肝内胆管癌中的差异表达
Pathol Res Pract. 2018 Aug;214(8):1136-1141. doi: 10.1016/j.prp.2018.06.011. Epub 2018 Jun 19.
4
Past, present, and future of chemically induced hepatocarcinogenesis rodent models: Perspectives concerning classic and new cancer hallmarks.化学诱导肝癌发生的啮齿动物模型的过去、现在和未来:关于经典和新癌症标志的观点。
Life Sci. 2023 Oct 1;330:121994. doi: 10.1016/j.lfs.2023.121994. Epub 2023 Aug 3.
5
Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis.Nrf2 的基因失活可预防大鼠肝癌发生的营养模型中起始细胞的克隆扩张。
J Hepatol. 2018 Sep;69(3):635-643. doi: 10.1016/j.jhep.2018.05.010. Epub 2018 Jun 22.
6
Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression.利用CD105和CD34免疫表达通过自动分析检测再生结节至小肝细胞癌的微血管密度
BMC Cancer. 2014 Feb 7;14:72. doi: 10.1186/1471-2407-14-72.
7
Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.人肝细胞癌中血管内皮生长因子、微血管密度的定量分析及其临床病理特征
Hepatobiliary Pancreat Dis Int. 2005 May;4(2):220-6.
8
Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity.具有良性特征的非典型高分化肝细胞癌:一种新的临床实体。
Intervirology. 2004;47(3-5):227-37. doi: 10.1159/000078475.
9
VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma.在肝细胞癌小鼠模型中,血管内皮生长因子-D(VEGF-D)促进肿瘤生长和淋巴转移。
Int J Cancer. 2008 Jun 1;122(11):2471-81. doi: 10.1002/ijc.23439.
10
Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma.内皮祖细胞促进肝癌血管生成。
World J Gastroenterol. 2012 Sep 21;18(35):4925-33. doi: 10.3748/wjg.v18.i35.4925.

引用本文的文献

1
Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment.针对CD47-SIRPα信号通路的治疗策略在胃肠道癌症治疗中的应用
J Pharm Anal. 2025 Jan;15(1):101099. doi: 10.1016/j.jpha.2024.101099. Epub 2024 Sep 12.

本文引用的文献

1
Mouse Models of Liver Parenchyma Injuries and Regeneration.肝脏实质损伤与再生的小鼠模型
Front Cell Dev Biol. 2022 May 5;10:903740. doi: 10.3389/fcell.2022.903740. eCollection 2022.
2
Hepatocyte-Specific Knock-Out of Nfib Aggravates Hepatocellular Tumorigenesis via Enhancing Urea Cycle.通过增强尿素循环,Nfib在肝细胞中的特异性敲除会加剧肝细胞肿瘤发生。
Front Mol Biosci. 2022 May 17;9:875324. doi: 10.3389/fmolb.2022.875324. eCollection 2022.
3
Suppressors of Cytokine Signaling and Hepatocellular Carcinoma.细胞因子信号转导抑制因子与肝细胞癌
Cancers (Basel). 2022 May 22;14(10):2549. doi: 10.3390/cancers14102549.
4
Evaluation of ATAD2 as a Potential Target in Hepatocellular Carcinoma.评估 ATAD2 作为肝细胞癌的潜在治疗靶点。
J Gastrointest Cancer. 2021 Dec;52(4):1356-1369. doi: 10.1007/s12029-021-00732-9. Epub 2021 Nov 5.
5
Correlation of in vivo imaging to morphomolecular pathology in translational research: challenge accepted.转化研究中体内成像与形态分子病理学的相关性:接受挑战。
EJNMMI Res. 2021 Aug 28;11(1):83. doi: 10.1186/s13550-021-00826-2.
6
Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management.应对全球肝细胞癌:流行病学、预防与管理
J Gastrointest Oncol. 2021 Jul;12(Suppl 2):S361-S373. doi: 10.21037/jgo.2020.02.08.
7
Experimental Models of Hepatocellular Carcinoma-A Preclinical Perspective.肝细胞癌的实验模型——临床前视角
Cancers (Basel). 2021 Jul 21;13(15):3651. doi: 10.3390/cancers13153651.
8
Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌的流行病学
JHEP Rep. 2021 May 11;3(4):100305. doi: 10.1016/j.jhepr.2021.100305. eCollection 2021 Aug.
9
Cancer statistics for the year 2020: An overview.2020年癌症统计数据概述。
Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588.
10
Angiodiversity and organotypic functions of sinusoidal endothelial cells.窦状内皮细胞的血管多样性和器官样功能。
Angiogenesis. 2021 May;24(2):289-310. doi: 10.1007/s10456-021-09780-y. Epub 2021 Mar 21.